Tate & Lyle Ventures, the US$45m venture capital fund specialising in the renewable ingredients, food technologies and renewable resources fields, has announced its first investment, in the UK-based food safety diagnostics company Lumora.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Set up by two leading biotechnology academics, Dr Laurence Tisi and Professor Jim Murray from Cambridge University’s Institute of Biotechnology, Lumora has developed a revolutionary DNA-based test that will identify and measure specific food-borne pathogens within a matter of hours.
According to Tate & Lyle Investments, the Lumora test is extremely rapid, highly sensitive and, importantly for the food sector, cost effective and easy to use. The investment by Tate & Lyle Ventures will enable Lumora to produce its next generation prototypes and install them within a range of food sector companies.
“We are delighted to be backing a company based on such strong science and technology, and robust intellectual property, which has the potential to transform not just food safety but also impact a range of other business sectors,” said Simon Barnes of Tate & Lyle Ventures. “Laurence Tisi and Jim Murray have established a business with great potential and we believe the Tate & Lyle link can add real value to this business.”
Laurence Tisi said: “In addition to providing finance to accelerate Lumora’s product development, Tate & Lyle Ventures brings valuable expertise in the food sector. The combination of Lumora’s unique technology with the backing of Tate & Lyle Ventures ideally positions Lumora to make a major impact on the food sector, benefiting consumers and food producers alike.”

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData